Product logins

Find logins to all Clarivate products below.


Cardiac Rhythm Management Devices | Medtech 360 | Market Analysis | Europe (Supplemental) | 2018

The mature European CRM device market will remain flat through 2026, as a result of flat generator unit sales, rising ICM procedure volumes, and price erosion. Adoption of premium-priced devices such as MRI-conditional devices, leadless pacemakers, and S-ICDs will help mitigate price erosion to a small extent.

This Medtech 360 Report provides key market metrics for the  CRM devices market in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will be supported by sustained demand for surgical revascularization in patients with increasingly complex CAD, where CABG remains the preferred treatment option…
Report
Cardiac Rhythm Management Devices – Market Insights – United States
The US CRM device market is expected to grow rapidly through 2034, driven by the increasing adoption of innovative devices, such as dual-chamber leadless pacemakers and extravascular ICDs. These…
Report
Diagnostic Imaging Systems – Market Insights – Japan
Japan’s diagnostic imaging system market will experience slow growth through 2034, driven by continuous technological advancement and rising hospital demand for efficient, patient-centric imaging…